Ex vivo renal artery reconstruction.

Annals of Surgery
F O BelzerR J Stoney

Abstract

Ex vivo renal artery reconstruction and autotransplantation is a relatively recent addition to the surgical armamentarium for renal vascular hypertension. Ten consecutive patients were considered for this surgical therapy and form the basis of this communication. The patients were treated by a combination of methods including bilateral ex vivo reconstruction, unilateral in situ and contralateral ex vivo reconstruction, and unilateral ex vivo reconstruction and contralateral nephrectomy. Replacement of the diseased segment of the renal artery in all ex vivo reconstruction consisted of arterial autografts including hypogastric artery, splenic artery, common iliac, and external iliac artery. In the ex vivo reconstruction, the ureter was either left intact or was transected and reconstructed by standard ureterovesicle implantation. After surgery all patients became normotensive without antihypertensive medication. Although this is a relatively small series, the uniform good results in these patients with extensive disease suggest that ex vivo renal artery reconstruction is a safe and effective method of treatment. Thus, it should be more widely applicable, expecially in those patients with renal vascular disease who were previously...Continue Reading

References

Oct 1, 1974·Archives of Surgery·R M HoffmannF O Belzer
Oct 1, 1974·Annals of Surgery·R H DeanJ H Foster
Dec 1, 1972·Archives of Surgery·R C LimF W Blaisdell
Sep 1, 1966·Annals of Surgery·J S NajarianP Braunstein
Mar 1, 1967·Archives of Surgery·K OtaA Ueno

❮ Previous
Next ❯

Citations

Jul 1, 1988·Transplant International : Official Journal of the European Society for Organ Transplantation·R J StrattaF O Belzer
Jan 1, 1981·Urologic Radiology·Y ShihD Gordon
Jun 21, 2001·ANZ Journal of Surgery·C S ChoA D Hibberd
Feb 28, 1980·The New England Journal of Medicine·J E Thompson, W V Garrett
Jun 1, 1983·Annals of Surgery·J C McDonaldW Y Tucker
Sep 1, 1987·Annals of Surgery·K C KentR J Stoney
Nov 1, 1996·International Journal of Urology : Official Journal of the Japanese Urological Association·A ToshinoM Mannami
Oct 1, 1977·The Australian and New Zealand Journal of Surgery·I R GoughG J Clunie
Sep 1, 1984·Archives of Disease in Childhood·F EkeB E Hardy
Dec 24, 2013·Current Urology Reports·J GonzálezJ I Martínez-Salamanca
Dec 1, 1989·European Journal of Vascular Surgery·J H van BockelJ L Terpstra
Aug 26, 2015·Journal of Vascular Surgery·Adriana LaserMarshall E Benjamin
Mar 1, 1991·Annals of Vascular Surgery·J P HarrisJ May
Jun 1, 1978·The Journal of Urology·A C NovickS Benjamin
Jan 1, 1978·The Journal of Urology·O SalvatierraR J Stoney
Mar 1, 1983·The Japanese Journal of Surgery·J KumazawaS Momose
Mar 1, 1980·The Journal of Urology·R K Lawson
Jul 1, 1982·The Journal of Urology·G E BrannenD M Cumes
Dec 1, 1990·The Journal of Urology·P A MerguerianB M Churchill
Jan 1, 1984·Scandinavian Journal of Urology and Nephrology·B Bugge-AsperheimA Flatmark
Sep 1, 1977·The Journal of Urology·B H StewartR A Straffon
Aug 1, 1980·The Journal of Urology·H HidaiS Fujishima
Sep 30, 1998·Chirurgie; mémoires de l'Académie de chirurgie·M Lacombe
May 14, 2020·European Journal of Vascular and Endovascular Surgery : the Official Journal of the European Society for Vascular Surgery·Jérémie JayetFabien Koskas
Aug 27, 2021·Annals of Vascular Surgery·Emanuele ContariniRobert C Minnee

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antihypertensive Agents: Mechanisms of Action

Antihypertensive drugs are used to treat hypertension (high blood pressure) which aims to prevent the complications of high blood pressure, such as stroke and myocardial infarction. Discover the latest research on antihypertensive drugs and their mechanism of action here.

Allogenic & Autologous Therapies

Allogenic therapies are generated in large batches from unrelated donor tissues such as bone marrow. In contrast, autologous therapies are manufactures as a single lot from the patient being treated. Here is the latest research on allogenic and autologous therapies.